ArticleFrontiers in immunology2026
Gut-derived small extracellular vesicles support trained innate immune tolerance in murine microglial cells.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Microglia are the resident immune cells of the central nervous system (CNS) that maintain tissue homeostasis and contribute to the pathogenesis of neuroinflammatory disorders. As innate immune cells, microglia can acquire memory-like states that exert long-term effects on CNS function and disease susceptibility. Increasing evidence highlights a dynamic interaction between the gut microbiota and the CNS, shaping microglial maturation and responsiveness throughout life. In addition to soluble microbial metabolites, gut-derived extracellular vesicles (EVs), including vesicles of microbial origin, have emerged as important mediators of microbiota-host communication capable of modulating brain homeostasis and inflammatory signaling; however, their role in programming microglial immune memory remains unclear. Methods: Here, we examined whether gut-derived small EVs influence memory-like features of primary murine microglia Results: Small EV priming followed by secondary LPS challenge induced a trained innate immune tolerance phenotype characterized by reduced pro-inflammatory mediator release and attenuated TLR2/4-MyD88-p38 MAPK signaling. This tolerant state was accompanied by suppressed glycolytic activity and decreased levels of activating histone H3 marks, indicating coordinated metabolic and epigenetic reprogramming. Notably, despite diminished inflammatory signaling, small EV-primed microglia displayed enhanced migratory and phagocytic capacities associated with increased ERK1/2 activation. Discussion: Together, these findings indicate that gut-derived small EVs can imprint memory-like programs in microglia that restrain inflammatory activation while preserving essential effector functions
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.